Global Stem Cell Therapy Market | Limited Number of FDA Approved Therapies to Be a Key Trend

The stem cell therapy market is poised to grow by USD 588.22 million during 2020-2024, progressing at a CAGR of almost 7% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005797/en/

Technavio has announced its latest market research report titled Global Stem Cell Therapy Market 2020-2024 (Graphic: Business Wire).

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The report on the stem cell therapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in awareness of stem cell therapy.

The stem cell therapy market analysis includes type and geography landscape. This study identifies the limited number of FDA-approved stem cell therapies as one of the prime reasons driving the stem cell therapy market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

The Stem Cell Therapy Market covers the following areas:

Stem Cell Therapy Market Sizing

Stem Cell Therapy Market Forecast

Stem Cell Therapy Market Analysis

Companies Mentioned

  • Gilead Sciences Inc.

  • Holostem Terapie Avanzate Srl

  • Lineage Cell Therapeutics Inc.

  • Lonza Group Ltd.

  • Novartis AG

  • Nuvasive Inc.

  • Organogenesis Inc.

  • Osiris Therapeutics Inc.

  • RTI Surgical Holdings Inc.

  • Vericel Corp. 

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

Five Forces Analysis

Market Segmentation by Type

  • Market segments

  • Comparison by Type

  • Allogeneic transplants – Market size and forecast 2019-2024

  • Autologous transplants – Market size and forecast 2019-2024

  • Market opportunity by Type

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America – Market size and forecast 2019-2024

  • Europe – Market size and forecast 2019-2024

  • APAC – Market size and forecast 2019-2024

  • South America – Market size and forecast 2019-2024

  • MEA – Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Gilead Sciences Inc.

  • Holostem Terapie Avanzate Srl

  • Lineage Cell Therapeutics Inc.

  • Lonza Group Ltd.

  • Novartis AG

  • Nuvasive Inc.

  • Organogenesis Inc.

  • Osiris Therapeutics Inc.

  • RTI Surgical Holdings Inc.

  • Vericel Corp.

Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201102005797/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Source Article